Double-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial

Double-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial

Introduction It is the common clinical practice to prescribe indefinite aspirin for patients with non-valvular atrial fibrillation (NVAF) post left atrial appendage occlusion (LAAO). However, aspirin as a primary prevention strategy for cardiovascular diseases has recently been challenged due to inc...

Full description

Bibliographic Details
Main Authors: Xiaochen Wang, Yansong Li, Bin Yang, Jian Sun, Mu Chen, Qunshan Wang, Peng-Pai Zhang, Bin-Feng Mo, Tai-Zhong Chen, Xiaoli Tang, Yi-Gang Li, Jian-An Wang, An-Li Tang; Hao Hu, Si-Ming Tao, Qi Lu, Zongjun Liu, Zhaohui Qiu, Chun Gui
Format: Article
Language:English
Published: BMJ Publishing Group 2021-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/3/e044695.full

Internet

https://bmjopen.bmj.com/content/11/3/e044695.full

Similar Items